the secret life of pets watch online with

It expects a Phase 3 flu vaccine interim efficacy analysis to be reviewed by an independent DSMB (data and safety monitoring board) before the end of the first quarter.

It expects to file for regulatory approval of its RSV vaccine for older adults in the first half. The company is still expecting about $5 billion in COVID sales that are contracted for delivery in 2023 and expects additional sales from key markets.

Product sales fell 30% to $4.9 billion, due to lower sales volume and lower demand vs. The decline in sales was mostly due to a steep fall in sales of the company’s COVID vaccines. The FactSet consensus was for EPS of $4.60 and revenue of $5.017 billion. Revenue fell to $5.084 billion from $7.211 billion a year ago.

MRNA said Thursday it had net income of $1.465 billion, or $3.61 a share, in the fourth quarter, down from $4.868 billion, or $11.29 a share, in the year-earlier period. Moderna earnings fall short of estimates amid steep decline in COVID vaccine sales, expects to file for approval of RSV vaccine in first half

The secret life of pets watch online with